Cyanotech Corp (CYAN) stock
CYANOTCMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
$0.70+0.00 (0.00%)
Close on Oct 19, 2026Market cap $5.11MP/E –Yield –
Cyanotech net income
Net income is the profit left for shareholders after every expense, interest and tax.
Cyanotech's net income for the twelve months ending Sep 30, 2025 was -$1.78M. For fiscal 2025 it was -$3.20M. The highest annual figure on record is $2.15M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | -$3.20M | – |
| FY2024 | Mar 31, 2024 | -$5.27M | – |
| FY2023 | Mar 31, 2023 | -$3.44M | -259.7% |
| FY2022 | Mar 31, 2022 | $2.15M | +134.1% |
| FY2021 | Mar 31, 2021 | $920.00K | +137.7% |
| FY2020 | Mar 31, 2020 | $387.00K | – |
| FY2019 | Mar 31, 2019 | -$3.60M | -450.8% |
| FY2018 | Mar 31, 2018 | $1.03M | – |
| FY2017 | Mar 31, 2017 | -$1.22M | – |
| FY2016 | Mar 31, 2016 | -$4.40M | – |
| FY2015 | Mar 31, 2015 | -$24.00K | – |
| FY2014 | Mar 31, 2014 | -$420.00K | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $1.00K | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$926.00K | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$627.00K | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$224.00K | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$1.15M | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$1.20M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$2.08M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$1.02M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$797.00K | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$1.37M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$1.43M | -616.2% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$598.00K | -254.9% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -$940.00K | -196.9% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -$472.00K | -190.8% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $277.00K | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $386.00K | -53.3% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $970.00K | +525.8% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $520.00K | +276.8% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$200.00K | -265.3% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $827.00K | +383.6% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $155.00K | -32.0% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $138.00K | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $121.00K | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $171.00K | -40.6% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $228.00K | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$133.00K | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$1.47M | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $288.00K | -74.0% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | -$1.14M | -339.2% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$1.28M | -354.5% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$1.06M | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $1.11M | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $475.00K | +379.8% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $501.00K | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | -$274.00K | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | -$349.00K | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $99.00K | – |
| Q1 FY2017CQ2 2016 | Jun 30, 2016 | -$691.00K | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | -$4.05M | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -$250.00K | – |
See a number that looks wrong?